A non-compliant medical balloon, where the non-compliant medical balloon may be changed from a deflated state to an inflated state by increasing pressure within the balloon, is made with a first fiber layer, a second fiber layer over said first fiber layer such that the fibers of the first fiber layer and the fibers of the second fiber layer form an angle and a binding layer coating the first fiber layer and said second fiber layer. The interior surface area of the non-compliant medical balloon remains unchanged when the balloon changes from a deflated state to an inflated state.

Patent
   8864704
Priority
Jun 14 1996
Filed
Oct 20 2006
Issued
Oct 21 2014
Expiry
Jul 24 2018

TERM.DISCL.
Extension
407 days
Assg.orig
Entity
Large
0
72
EXPIRED<2yrs
22. A non-compliant medical balloon having opposing ends, comprising:
an inner polymeric wall capable of sustaining pressure when inflated and a polymeric reinforcing wall surrounding the inner polymeric wall;
the polymeric reinforcing wall including a polymer, a plurality of first inelastic fibers and a second inelastic fiber together defining an outer surface, the plurality of first fibers being made of a fiber different from the second fiber;
the plurality of first fibers extending substantially parallel to a balloon axis extending between the opposing ends;
the second fiber being disposed around the balloon axis and substantially perpendicular to the plurality of first fibers.
13. A non-compliant medical balloon having opposing ends and a long axis, comprising:
a polymeric wall capable of sustaining pressure when inflated and defining a cylindrical shape when inflated;
at least a portion of the wall having a plurality of first fibers and at least a second fiber bonded together to the wall;
the plurality of first fibers being substantially parallel to the long axis and the at least one second fiber being substantially perpendicular to the plurality of first fibers; and
a polymeric solution applied to the plurality of first fibers and the at least one second fiber together defining an outer surface such that the wall substantially maintains the cylindrical shape during subsequent deflation and inflation of the balloon.
1. A non-compliant medical balloon, comprising:
a surface defining a cylindrical shape with a circumference and a long axis when in an inflated or deflated state;
a plurality of first inelastic fibers attached to an exterior of the surface, said plurality of first fibers being substantially equal in length to a length of the long axis and extending substantially parallel to the length of the long axis;
at least a second inelastic fiber attached to the plurality of first fibers, said at least one second fiber extending radially around the circumference and substantially over the length of the long axis; and
a polymeric solution applied to the plurality of first fibers and the at least one second fiber together defining an outer surface such that the surface substantially maintains the cylindrical shape during subsequent deflation and inflation of the balloon.
29. A polymeric medical balloon having a surface with a circumference and a long axis when in an inflated or deflated state, comprising:
an adhesive applied directly to the surface in the inflated state;
a plurality of first inelastic fibers attached to the surface, said plurality of first fibers positioned substantially equidistantly from one another and extending substantially parallel to the long axis;
a second inelastic fiber attached to the plurality of first fibers, said second fiber extending substantially perpendicular to the plurality of first fibers;
a third inelastic fiber attached to the plurality of first fibers, said third fiber extending in an opposite direction of the second fiber and substantially perpendicular to the plurality of first fibers; and
a polymeric solution applied to the plurality of first and second fibers to form a fiber/polymeric matrix defining an outer surface.
2. The balloon as in claim 1, the balloon having a surface area that does not change when the balloon changes from the deflated state to the inflated state.
3. The balloon as in claim 1, further comprising an adhesive applied to the surface under the plurality of first fibers.
4. The balloon as in claim 1, further comprising a third inelastic fiber running opposite to the at least one second fiber and substantially perpendicular to the plurality of first fibers.
5. The balloon as in claim 1, the plurality of first fibers including at least one of Kevlar, Vectran, Spectra, Dacron, Dyneema, Terlon (PBT), Zylon (PBO), Polyimide (PIM), and ultra high molecular weight polyethylene.
6. The balloon as in claim 1, the plurality of first fibers including 15 to 30 fibers having a fiber thickness of about 0.0005 to 0.001 inches.
7. The balloon as in claim 1, the plurality of first fibers being positioned substantially equidistant from one another.
8. The balloon as in claim 1, the at least one second fiber including at least one of Kevlar, Vectran, Spectra, Dacron, Dyneema, Teflon (PBT), Zylon (PBO), Polyimide (PIM), and ultra high molecular weight polyethylene.
9. The balloon as in claim 1, the at least one second fiber being substantially perpendicular to the plurality of first fibers.
10. The balloon as in claim 1, the at least one second fiber having a thickness of about 0.0005 to 0.001 inches.
11. The balloon as in claim 1, the at least one second fiber having a wind density of about 50 to 80 wraps per inch.
12. The balloon as in claim 1, wherein the plurality of first fibers form an acute or right angle with respect to the at least one second fiber.
14. The balloon as in claim 13, the plurality of first fibers being substantially equal in length to a length of the long axis and extending along the length of the long axis.
15. The balloon as in claim 13, the at least one second fiber extending radially around the circumference of the long axis and substantially over the length of the long axis.
16. The balloon as in claim 13, wherein the plurality of first fibers form an acute angle with respect to the at least one second fiber.
17. The balloon as in claim 13, wherein the plurality of first fibers form a right angle with respect to the at least one second fiber.
18. The balloon as in claim 13, the polymeric solution and the polymeric wall including at least one of polyethylene, polyethylene terephthalate (PET), polycaprolactam, polyester, polyether, polyamide, polyurethane, polyimide, ABS copolymer, polyester/polyether block copolymer, ionomer resin, liquid crystal polymer, and rigid rod polymer.
19. The balloon as in claim 13, the balloon including at least one of polyethylene, polyethylene terephthalate (PET), polycaprolactam, polyester, polyether, polyamide, polyurethane, polyimide, ABS copolymer, polyester/polyether block copolymer, ionomer resin, liquid crystal polymer, and rigid rod polymer.
20. The balloon as in claim 13, the balloon being made of a polymer the same as the polymeric wall.
21. The balloon as in claim 13, the balloon being made of a polymer different from the polymer of the polymeric wall.
23. The balloon as in claim 22, further comprising a third inelastic fiber running opposite to the second fiber and substantially perpendicular to the plurality of first fibers.
24. The balloon as in claim 23, further comprising an adhesive being applied to the plurality of first fibers, the second fiber and the third fiber.
25. The balloon as in claim 23, wherein the plurality of first fibers form an acute or right angle with respect to the second fiber.
26. The balloon as in claim 22, the inner polymeric wall and the polymeric reinforcing wall including at least one of polyethylene, polyethylene terephthalate (PET), polycaprolactam, polyester, polyether, polyamide, polyurethane, polyimide, ABS copolymer, polyester/polyether block copolymer, ionomer resin, liquid crystal polymer, and rigid rod polymer.
27. The balloon as in claim 22, the plurality of first fibers and the second fiber including at least one of Kevlar, Vectran, Spectra, Dacron, Dyneema, Talon (PBT), Zylon (PBO), Polyimide (PIM), and ultra high molecular weight polyethylene.
28. The balloon as in claim 22, the plurality of first fibers being made of a fiber the same as the second fiber.
30. The balloon as in claim 29, wherein the polymeric solution is the same polymer as the polymeric balloon.
31. The balloon as in claim 29, wherein the polymeric solution is a different polymer than the polymeric balloon.
32. The balloon as in claim 29, the plurality of first fibers being substantially equal in length to a length of the long axis and extending substantially along the length of the long axis.
33. The balloon as in claim 29, the second and third fibers extending radially around the circumference substantially over the length of the long axis.

This application is a divisional of prior application Ser. No. 10/726,960, filed on Dec. 3, 2003, which is a continuation of U.S. patent application Ser. No. 09/523,817, filed Mar. 13, 2000, now U.S. Pat. No. 6,746,425, which is a continuation-in-part of U.S. patent application Ser. No. 08/873,413, filed Jun. 12, 1997 now abandoned, which claim benefit of U.S. provisional application No. 60/019,931, filed Jun. 14, 1996, the entire disclosures of which are incorporated by reference herein.

This invention relates to the field of balloons that are useful in angioplasty and other medical uses.

Catheters having inflatable balloon attachments have been used for reaching small areas of the body for medical treatments, such as in coronary angioplasty and the like. Balloons are exposed to large amounts of pressure. Additionally, the profile of balloons must be small in order to be introduced into blood vessels and other small areas of the body. Therefore, materials with high strength relative to film thickness are chosen. An example of these materials is PET (polyethylene terephthalate), which is useful for providing a non-compliant, high-pressure device. Unfortunately, PET and other materials with igh strength-to-film thickness ratios tend to be scratch- and puncture-sensitive. Polymers that tend to be less sensitive, such as polyethylene, nylon, and urethane are compliant and, at the same film thickness as the non-compliant PET, do not provide the strength required to withstand the pressure used for transit in a blood vessel and expansion to open an occluded vessel. Non-compliance, or the ability not to expand beyond a predetermined size on pressure and to maintain substantially, a profile, is a desired characteristic for balloons so as not to rupture or dissect the vessel as the balloon expands. Further difficulties often arise in guiding a balloon catheter into a desired location in a patient due to the friction between the apparatus and the vessel through which the apparatus passes. The result of this friction is failure of the balloon due to abrasion and puncture during handling and use and also from over-inflation.

The present invention is directed to a non-compliant medical balloon suitable for angioplasty and other medical procedures and which integrally includes very thin inelastic fibers having high tensile strength, and methods for manufacturing the balloon. The fiber reinforced balloons of the present invention meet the requirements of medical balloons by providing superior burst strength; superior abrasion-, cut- and puncture-resistence; and superior structural integrity.

More particularly, the invention is directed to a fiber-reinforced medical balloon having long axis, wherein the balloon comprises an inner polymeric wall capable of sustaining pressure when inflated or expanded into a fiber/polymeric matrix outer wall surrounding and reinforcing the inner polymeric wall. The fiber/polymeric matrix outer wall is formed from at least two layers of fibers and a polymer layer. The fibers of the first fiber layer are substantially equal in length to the length of the long axis of the balloon and run along the length of the long axis. But “substantially equal in length” is meant that the fiber is at least 75% as long as the length of the long axis of the balloon, and preferably is at least 90% as long. The fiber of the second fiber layer runs radically around the circumference of the long axis of the balloon substantially over the entire length of the long axis. By “substantially over the entire length” is meant that the fiber runs along at least the center 75% of the length of the long axis of the balloon, and preferably runs along at least 90% of the length. The fiber of the second fiber layer is substantially perpendicular to the fibers of the first fiber layer. By “substantially perpendicular to” is meant that the fiber of the second fiber layer can be up to about 10 degrees from the perpendicular.

The invention is further directed to processes for manufacturing a non-compliant medical balloon. In one embodiment, a thin layer of a polymeric solution is applied over a mandrel, the mandrel having the shape of a medical balloon and being removable from the finished product. High-strength inelastic fibers are applied to the thin layer of polymer with a first fiber layer having fibers running substantially along the length of the long axis of the balloon and a second fiber layer having fiber running radially around the circumference of the long axis substantially over the entire length of the long axis. The fibers are then coated with a thin layer of a polymeric solution to form a fiber/polymeric matrix. The polymers are cured and the mandrel is removed to give the fiber-reinforced medical balloon.

In another embodiment of the invention, a polymer balloon is inflated and is maintained in its inflated state, keeping the shape of the balloon. High-strength inelastic fibers are applied to the surface of the balloon, with a first fiber layer having fibers running substantially along the length of the long axis of the balloon and a second fiber layer having fiber running radially around the circumference of the long axis substantially over the entire length of the long axis. The fibers are then coated with a thin layer of a polymeric solution to form a fiber/polymeric matrix. The fiber/polymeric matrix is cured to give the fiber-reinforced medical balloon, which can then be deflated for convenience, until use.

In a presently preferred embodiment, a thin coating of an adhesive is applied to the inflated polymer balloon or to the polymer-coated mandrel prior to applying the inelastic fibers.

FIG. 1 illustrates an inflated standard medical balloon, which is used in the invention as the base of the final composite fiber-reinforced balloon.

FIG. 2 illustrates an inflated standard medical balloon, which is used in this invention as the base of the final composite fiber-reinforced balloon.

FIG. 3 illustrates the positioning of the second layer of fiber over the first fiber layer. The fiber is wound radially around the long axis substantially over the entire length of the long axis of the balloon, each wrap being substantially equally spaced from the others. The fiber runs substantially perpendicular to the fibers of the first fiber layer.

FIG. 4 illustrates the positioning of the third layer of fiber over the second fiber layer, in accordance with another embodiment.

Referring now to the drawings, wherein like reference numbers are used to designate like elements throughout the various views, several embodiments of the present invention are further described. The figures are not necessarily drawn to scale, and in some instances the drawings have been exaggerated or simplified for illustrative purposes only. One of ordinary skill in the art will appreciate the many possible applications and variations of the present invention based on the following examples of possible embodiments of the present invention.

A medical balloon in accordance with the present invention in one embodiment begins with an inflated polymeric balloon 2, as shown in FIG. 1, to which there is applied by hand or mechanically, inelastic fiber or filament 4, as shown in FIG. 2. This is sometimes referred to as the “primary wind.” To assist in placement and retention of the fibers, there can be applied an adhesive to either the inflated balloon surface or to the fiber. The purpose of this first application of fiber is to prevent longitudinal extension (growth) of the completed balloon.

An alternate method of applying the longitudinal fibers involves first creating a fabric of longitudinal fibers by pulling taut multiple parallel fibers on a flat plate and coating with a polymeric solution to create a fabric. The fabric is then cut into a pattern such that it can be wrapped around the base balloon or mandrel.

Next, a second application of inelastic fiber 6 is applied to the circumference of the balloon, as shown in FIG. 3. This is sometimes referred to as the “hoop wind.” The purpose of the hoop wind is to prevent or minimize distension of the completed balloon diameter during high inflation pressures.

After the hoop wind is completed, the exterior of the fiber-wound inflated balloon is coated with a polymeric solution and cured to form a composite, con-compliant fiber-reinforced medical balloon. The outer polymeric coating of the fiber/polymeric matrix secures and bonds the fibers to the underlying inflated balloon so that movement of the fibers is restricted during deflation of the composite balloon and subsequent inflation and deflation during use of the balloon. The polymeric solution can be applied several times, if desired. The polymeric solution can use the same polymer as or a polymer different from the polymer of the inflated polymeric balloon 2. The polymers should be compatible so that separation of the composite balloon is prevented or minimized.

In a second method of making a medical balloon of the present invention, a removable mandrel having the shape that is identical to the shape of the inside of the desired balloon is used. A shape such as shown in FIG. 1 is suitable. The mandrel can be made of collapsible metal or polymeric bladder, foams, waxes, low-melting metal alloys, and the like. The mandrel is first coated with a layer of a polymer, which is then cured. This forms the inner polymeric wall of the balloon. Next, repeating the steps as described above, the primary wind and the hoop wind are placed over the inner polymer wall, followed by a coating with a polymeric solution and curing thereof to form a fiber/polymeric matrix outer wall. Finally, the mandrel is removed, by methods known in the art such as by mechanical action, by solvent, or by temperature change, to give the composite medical balloon of the invention.

In view of the high strength of the balloons of the present invention, it is possible to make balloons having a wall thickness less than conventional or prior art balloons without sacrifice of burst strength, abrasion resistence, or puncture resistance. The balloon wall thickness can be less than the thickness given in the examples hereinbelow.

In addition, the fiber-reinforced balloons of the present invention are non-complaint. That is, they are characterized by minimal axial stretch and minimal radial distention and by the ability not to expand beyond a predetermined size on pressure and to maintain substantially a profile.

Polymers and copolymers that can be used for the base balloon and/or the covering layer of the fiber/polymeric matrix include the conventional polymers and copolymers used in medical balloon construction, such as, but not limited to, polyethylene, polyethylene terephthalate (PET), polycaprolactam, polyesters, polyethers, polyamides, polyurethanes, polyimides, ABS copolymers, polyester/polyether block copolymers, ionomer resins, liquid crystal polymers, and rigid rod polymers.

The high-strength fibers are chosen to be inelastic. By “inelastic,” as used herein and in the appended claims, is meant that the fibers have very minimal elasticity or stretch. Zero elasticity or stretch is probably unobtainable taking into account the sensitivity of modern precision test and measurement instruments, affordable costs and other factors. Therefore, the term “inelastic” should be understood to mean fibers that are generally classified as inelastic but which, nevertheless, may have a detectable, but minimal elasticity or stretch. High strength inelastic fibers useful in the present invention include but are not limited to; Kevlar, Vectran, Spectra, Dacron, Dyneema, Terlon (PBT), Zylon (PBO), Polyimide (PIM), ultra high molecular weight polyethylene, and the like. In a presently preferred embodiment, the fibers are ribbon-like; that is, they have a flattened to a rectangular shape. The fibers of the first fiber layer may be the same as or different from the fiber of the second fiber layer.

The most advantageous density of the fiber wind is determinable through routine experimentation by one of ordinary skill in the art given the examples and guidelines herein. With respect to the longitudinally-placed fibers (along the long axis of the balloon) of the first fiber layer, generally about 15 to 30 fibers having a fiber thickness of about 0.0005 to 0.001 inch and placed equidistant from one another will provide adequate strength for a standard-sized medical balloon. With respect to the fiber of the hoop wind, or second fiber layer, fiber having a thickness of about 0.0005 to 0.001 inch and a wind density within the range of about 50 to 80 wraps per inch is generally adequate. The fiber of the second fiber layer is preferably continuous and is, for a standard-sized medical balloon, about 75-100 inches long.

The longitudinally placed fibers should be generally parallel to or substantially parallel to the long axis of the balloon or maximum longitudinal stability (non-stretch) of the balloon. The fibers of the hoop wind should be perpendicular to or substantially perpendicular to the fibers placed longitudinally for maximum radial stability (non-stretch) of the balloon. This distributes the force on the balloon surface equally and creates “pixels” of equal shape and size. In the case where the fibers of the hoop wind are at a small acute angle (e.g. about 10 degrees or more) to the longitudinal fibers, two hoop winds (in opposite direction) can be used for minimizing radial distention. FIG. 4 depicts a balloon having a second hoop wind 12.

The following examples are provided to illustrate the practice of the present invention, and are intended neither to define nor to limit the scope of the invention in any manner.

An angioplasty balloon, as shown in FIG. 1, having a wall thickness of 0.0008 inch is inflated to about 100 psi, and the two open ends of the balloon are closed off. The inflation pressure maintains the shape (geometry) of the balloon in an inflated profile during the construction of the composite balloon. The balloon is a blow-molded balloon of highly oriented polyethylene terephthalate (PET). To the inflated balloon is applied a very thin coat of 3M-75 adhesive to hold the fibers sufficiently to prevent them from slipping out of position after placement on the balloon.

Kevlar® fibers are placed, by hand, along the length of the balloon as shown in FIG. 2 to provide the primary wind. Each of the fibers is substantially equal in length to the length of the long axis of the balloon. Twenty-four fibers are used, substantially equally spaced from each other. The fiber used for the primary wind has a thickness of 0.0006 inch.

Next, a hoop wind of Kevlar® fiber is applied radially around the circumference of and over substantially the entire length of the long axis of the balloon, as shown in FIG. 3. The fiber has a thickness of 0.0006 inch and is applied at a wind density of 60 wraps per inch.

The fiber-wound based PET balloon is then coated with a 10% solution of Texin® 5265 polyurethane in dimethylacetamide (DMA) and allowed to cure at room temperature. Five additional coating of the polurethane solution are applied in about 6-hour increments, after which the pressure in the balloon is released. The resulting composite fiber-reinforced balloon is non-compliant and exhibits superior burst strength and abrasion and puncture resistance.

3M-75 is a tacky adhesive available from 3M Company, Minneapolis, Minn. Kevlar® is a high strength, inelastic fiber available from the DuPont Company, Wilmington, Del. Texin® 5265 is a polyurethane polymer available from Miles, Inc., Pittsburgh, Pa.

The procedure of Example 1 was repeated with the exception that Vectran® fiber, having a thickness of 0.0005 inch is used in place of the Kevlar® fiber. The resulting composite balloon is axially and radially non-compliant at very high working pressures. The balloon has a very high tensile strength and abrasion and puncture resistance.

Vectran® is a high strength fiber available from Hoechst-Celanese, Charlotte, N.C.

A mandrel in the shape of a balloon as shown in FIG. 1 is made of a water-soluble wax. The wax mandrel is coated with a very thin layer (0.0002 inch) of Texin® 5265 polyurethane. After curing, adhesive and Vectran® fibers are applied, following the procedure of Example 1. Next, several coats of Texin® 5265 polyurethane as applied in Example 1. The wax is then exhausted by dissolving in hot water to give a non-compliant, very high strength, abrasion-resistant, composite fiber-reinforced balloon.

The procedure of Example 3 is repeated using high strength Spectra® fiber in place of Vectran® fiber. Spectra® fiber is available from Allied Signal, Inc., Morristown, N.J.

The procedure of Example 1 is repeated using Ultra High Molecular Weight Polyethylene (Spectra 2000) fiber, which has been flattened on a roll mill. To the flattened fiber is applied a thin coat of a solution of 1-MP Tecoflex® adhesive in a 60-40 solution of methylene chloride and methylethylketone. The fiber is applied to the balloon as in Example 1 using 30 longitudinal fibers, each substantially equal in length to the length of the long axis of the balloon, and a hoop wind of 54 wraps per inch. The fibers are then coated with the Tecoflex® solution.

Tecoflex® is supplied by Thermedics, Inc., Woburn, Mass.

A balloon-shaped solid mandrel made of a low melting temperature metal alloy is coated with a thin layer of Texin® 5265/DMA solution (10%). Vectran® fibers are applied as in Example 1, followed by coating with Texin®/DMA. The metal mandrel is melted out using hot water. A very high strength, abrasion-resistant, composite balloon is obtained, which is non-compliant.

Following the procedures of Example 6, a mandrel is coated with a very thin layer of PIM polyimide (2,2-dimethylbenzidine) in solution in cyclopentanone. Polyimide fibers are applied, and the composite balloon is then completed with additional applications of the PIM solution. The mandrel is removed to give a high strength, puncture-resistant balloon having an extremely cohesive fiber/matrix composite wall that is resistant to delamination.

A balloon is constructed as in Example 7, except that the longitudinal fibers are replaced by a longitudinally oriented thin film made of polyimide LARC-1A film (available from IMITEC, Schenectady, N.Y.). The film is cut into a mandrel-shaped pattern and applied to the mandrel, over which the polyimide hoop fibers and the PIM solution are applied.

Although the illustrative embodiment has been described in detail, it should be understood that various changes, substitutions and alterations can be made therein without departing from the spirit and scope of the invention as defined by the appended claims.

Beckham, James P.

Patent Priority Assignee Title
Patent Priority Assignee Title
4367396, Jul 21 1980 PACE, INCORPORATED, A CORP OF MARYLAND Thermal tool including twisted tip for the tool and method of making tip
4572186, Dec 07 1983 Cordis Corporation Vessel dilation
4637396, Oct 26 1984 COOK INCORPORATED, A CORP OF INDIANA Balloon catheter
4702252, Oct 13 1983 SMITHS INDUSTRIES PUBLIC LMITED COMPANY Catheters
4796629, Jun 03 1987 Stiffened dilation balloon catheter device
5078727, Jul 14 1989 Catheters
5108416, Feb 13 1990 Medtronic Ave, Inc Stent introducer system
5112304, Mar 17 1989 B BRAUN MEDICAL INC Balloon catheter
5116360, Dec 27 1990 MAQUET CARDIOVASCULAR LLC Mesh composite graft
5171297, Mar 17 1989 Angeion Corporation Balloon catheter
5201706, May 09 1989 TORAY INDUSTRIES, INC Catheter with a balloon reinforced with composite yarn
5207700, Aug 08 1988 Boston Scientific Scimed, Inc Polyimide balloon catheter and method of forming a balloon therefor
5264260, Jun 20 1991 VENTION MEDICAL ADVANCED COMPONENTS, INC Dilatation balloon fabricated from low molecular weight polymers
5270086, Sep 25 1989 SciMed Life Systems, INC; Boston Scientific Scimed, Inc Multilayer extrusion of angioplasty balloons
5295960, Apr 01 1992 Applied Medical Resources Corporation Catheter with interior balloon
5304340, Sep 06 1991 C. R. Bard, Inc. Method of increasing the tensile strength of a dilatation balloon
5314443, Jun 25 1990 Boston Scientific Scimed, Inc Prostate balloon dilatation catheter
5330429, Sep 05 1989 Toray Industries, Inc. Catheter with a balloon reinforced with composite yarn
5338299, Mar 17 1989 Angeion Corporation Balloon catheter
5344401, Dec 20 1991 SciMed Life Systems, INC Catheter balloon formed from a polymeric composite
5358486, May 15 1990 Medtronic Ave, Inc Multiple layer high strength balloon for dilatation catheter
5451209, May 11 1992 Advanced Cardiovascular Systems, Inc. Intraluminal catheter with a composite shaft
5470314, Jul 22 1994 Perfusion balloon catheter with differential compliance
5477886, Jan 26 1994 J VAN BEUGEN BEHEER B V Inflatable closing plug for pipes and method of manufacturing same
5478320, Nov 29 1989 Cordis Corporation Puncture resistant balloon catheter and method of manufacturing
5492532, Mar 17 1989 B. Braun Medical, Inc.; B BRAUN MEDICAL, INC Balloon catheter
5549552, Mar 02 1995 Boston Scientific Scimed, Inc Balloon dilation catheter with improved pushability, trackability and crossability
5554120, Jul 25 1994 Advanced Cardiovascular Systems Polymer blends for use in making medical devices including catheters and balloons for dilatation catheters
5587125, Aug 15 1994 SciMed Life Systems, INC; Boston Scientific Scimed, Inc Non-coextrusion method of making multi-layer angioplasty balloons
5599576, Feb 06 1995 SURFACE SOLUTIONS LABORATORIES, INC Medical apparatus with scratch-resistant coating and method of making same
5647848, Jun 07 1995 Boston Scientific Scimed, Inc High strength low compliance composite balloon for balloon catheters
5755690, Jan 09 1987 Medtronic Ave, Inc Multiple layer high strength balloon for dilatation catheter
5759172, Apr 09 1996 Cordis Corporation Balloon catheter with lobed balloon and method for manufacturing such a catheter
5769817, Feb 28 1997 SciMed Life Systems, INC; Boston Scientific Scimed, Inc Coextruded balloon and method of making same
5772681, Mar 02 1993 Metra ApS Dilation catheter
5788979, Jul 22 1994 Boston Scientific Scimed, Inc Biodegradable coating with inhibitory properties for application to biocompatible materials
5797877, Oct 01 1993 Boston Scientific Scimed, Inc Medical device balloons containing thermoplastic elastomers
5820613, Jan 31 1995 Cordis Corporation Balloon catheter with reinforced and elastically deformable basic body
5868779, Aug 15 1997 Apparatus and methods for dilating vessels and hollow-body organs
5928181, Nov 21 1997 Advanced International Technologies, Inc. Cardiac bypass catheter system and method of use
5972441, Mar 02 1994 W L GORE & ASSOCIATES, INC Thin-wall polytetrafluoroethylene tube
6007544, Jun 14 1996 Beth Israel Deaconess Medical Center Catheter apparatus having an improved shape-memory alloy cuff and inflatable on-demand balloon for creating a bypass graft in-vivo
6010480, Aug 23 1993 Boston Scientific Scimed, Inc Balloon catheter
6012457, Jul 08 1997 Regents of the University of California, The Device and method for forming a circumferential conduction block in a pulmonary vein
6024722, Jan 06 1994 Boston Scientific Scimed, Inc Thermoplastic polyimide balloon catheter construction
6024740, Jul 08 1997 ATRIONIX, INC Circumferential ablation device assembly
6027779, Mar 02 1994 W L GORE & ASSOCIATES, INC Thin-wall polytetrafluoroethylene tube
6036697, Jul 09 1998 Boston Scientific Scimed, Inc Balloon catheter with balloon inflation at distal end of balloon
6117101, Jul 08 1997 Regents of the University of California, The Circumferential ablation device assembly
6124007, Mar 06 1996 Boston Scientific Scimed, Inc Laminate catheter balloons with additive burst strength and methods for preparation of same
6127597, Mar 07 1997 Kyphon SARL Systems for percutaneous bone and spinal stabilization, fixation and repair
6156254, Aug 02 1996 CREAGH MEDICAL LIMITED Method of manufacturing a balloon member for a balloon catheter
6164283, Jul 08 1997 Regents of the University of California, The Device and method for forming a circumferential conduction block in a pulmonary vein
6171297, Jun 30 1998 SciMed Life Systems, INC; Boston Scientific Scimed, Inc Radiopaque catheter tip
6183492, Aug 28 1997 Applied Medical Resources Corporation Perfusion-isolation catheter apparatus and method
6187013, Jun 06 1994 Boston Scientific Scimed, Inc Catheter with stent and method for the production of a catheter with stent
6234995, Nov 12 1998 ADVANCED INTERVENTIONAL TECHNOLOGIES, INC Apparatus and method for selectively isolating a proximal anastomosis site from blood in an aorta
6245064, Jul 08 1997 Atrionix, Inc. Circumferential ablation device assembly
6254599, May 09 1997 Atrionix, Inc. Circumferential ablation device assembly
6263236, Nov 29 1999 ENDOVASCULAR TECHNOLOGIES, INC Non-occlusive expandable catheter
6270902, Apr 23 1997 C. R. Bard, Inc. Method of improving the adherence of certain crosslinked polymer coatings containing PEO or PVP to a substrate
6290485, Mar 02 1995 Boston Scientific Scimed, Inc Mold for forming a balloon catheter having stepped compliance curve
6305378, Jul 08 1997 The Regents of the University of California Device and method for forming a circumferential conduction block in a pulmonary vein
6315751, Aug 15 1997 CLEVELAND CLINIC FOUNDATION, THE Cardiopulmonary bypass system using vacuum assisted venous drainage
6328925, Mar 06 1996 Boston Scientific Scimed, Inc Laminate catheter balloons with additive burst strength and methods for preparation of same
6626889, Jul 25 2001 Advanced Cardiovascular Systems, Inc. Thin-walled guiding catheter with improved radiopacity
6702782, Jun 26 2001 Stryker Corporation Large lumen balloon catheter
6905743, Feb 25 1999 Boston Scientific Scimed, Inc Dimensionally stable balloons
6911038, May 08 2001 Boston Scientific Scimed, Inc Matched balloon to stent shortening
6977103, Oct 25 1999 Boston Scientific Scimed, Inc Dimensionally stable balloons
20060085022,
WO9518647,
//
Executed onAssignorAssigneeConveyanceFrameReelDoc
Jul 22 2004FUTUREMED INTERVENTIONAL, INC C R BARD, INC ASSIGNMENT OF ASSIGNORS INTEREST SEE DOCUMENT FOR DETAILS 0234390992 pdf
Oct 20 2006C.R. Bard, Inc.(assignment on the face of the patent)
Date Maintenance Fee Events
Apr 05 2018M1551: Payment of Maintenance Fee, 4th Year, Large Entity.
Jun 13 2022REM: Maintenance Fee Reminder Mailed.
Nov 28 2022EXP: Patent Expired for Failure to Pay Maintenance Fees.


Date Maintenance Schedule
Oct 21 20174 years fee payment window open
Apr 21 20186 months grace period start (w surcharge)
Oct 21 2018patent expiry (for year 4)
Oct 21 20202 years to revive unintentionally abandoned end. (for year 4)
Oct 21 20218 years fee payment window open
Apr 21 20226 months grace period start (w surcharge)
Oct 21 2022patent expiry (for year 8)
Oct 21 20242 years to revive unintentionally abandoned end. (for year 8)
Oct 21 202512 years fee payment window open
Apr 21 20266 months grace period start (w surcharge)
Oct 21 2026patent expiry (for year 12)
Oct 21 20282 years to revive unintentionally abandoned end. (for year 12)